Hana Suzuki
Sleep & Cognition Writer
Hana covers the sleep, stress, and cognition corner of the peptide literature. She came from sleep science journalism and still reads polysomnography charts for fun.
Blocking an Aging Protein Regrew Cartilage in Mice
Stanford researchers blocked an aging linked enzyme and regrew knee cartilage in mice, with early signs in human tissue too.
Melanotan II Research Overview: What Studies Show About This Melanocortin Peptide
A look at what animal and human research actually shows about Melanotan II, from pigmentation to appetite to reported safety concerns.
GLP1 Study Looks At AFib Risk In Heart Failure
A new paper examines whether GLP1 drugs affect atrial fibrillation rates in obese HFpEF patients without diabetes.
PT 141: From Melanotan Research to an Approved Drug
PT 141 began as a melanocortin research compound and became bremelanotide, an FDA approved drug for low sexual desire in women.
New Study Compares Tirzepatide to Other GLP1 Drugs in IBD Patients
A propensity matched study looks at tirzepatide versus other GLP1 drugs in patients with inflammatory bowel disease.
MOTS c: The Mitochondrial Peptide Explained
MOTS c is a mitochondrial derived peptide studied for its effects on glucose, fat, and exercise adaptation in animal and cell research.
FDA Panel Recommends Semax for the Compounding List
An FDA panel voted to recommend Semax for a compounding list, not to approve it as a drug.